Skip to main content
Caplight Logo









QNTM Labs

QNTM Labs

Private
OdenseHealthcare & Life Scienceshttps://qntmlabs.com

Last Round

Series A

Nov 17, 2022

Total Funding Raised

$10.75M

Company Overview

QNTM Labs operates in Healthcare & Life Sciences and is based in Odense. Its latest recorded funding round was a Series A round in November 2022.

QNTM Labs is a laboratory services company that provides GMP-certified analytical testing, quality control, and research and development services for the pharmaceutical and medical cannabis industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Compliance, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

QNTM Labs Comparables

Compare QNTM Labs with similar companies based on industry and business-model similarity.

QNTM Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QPLab - Pharma Services, Lda.
92%
Nordic BioAnalysis AB
83%
Sure Laboratories
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

QNTM Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 17, 2022
SeedSep 29, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

QNTM Labs Investors

Notable investors and investment history

QNTM Labs investors
InvestorRounds
Intrinsic Capital PartnersSeries A
volvér.vcSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 5, 2025

    Grew 17% QoQ, from 29 to 34 employees.

  • May 7, 2025

    Grew 30% QoQ, from 27 to 35 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

QNTM Labs Filings

Explore SEC and related filing metadata, where available.

QNTM Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about QNTM Labs's valuation, stock price, and market status.

Is QNTM Labs a public or private company?

QNTM Labs is a private company.

What is the current stock price of QNTM Labs?

QNTM Labs is a private company, so its shares have no public market price. Caplight tracks QNTM Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is QNTM Labs worth (valuation)?

Valuation information for QNTM Labs is not publicly available.

Can I buy QNTM Labs stock?

QNTM Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was QNTM Labs's last funding round?

QNTM Labs's most recent funding round was Series A on November 17, 2022.

Who are the main investors in QNTM Labs?

Key investors in QNTM Labs include Intrinsic Capital Partners.

Will QNTM Labs IPO soon?

No public IPO plans have been announced for QNTM Labs.

How can I track QNTM Labs secondary market activity?

Caplight tracks bids, offers, and trades in QNTM Labs's shares on secondary markets.

Firmographic Details

HeadquartersOdense
Employee Range32
Year Founded2020
Last FundingNov 17, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?